Recent Patents on Drug Delivery & Formulation
Title: Patent Selections
Volume: 2 Issue: 2
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Patent Selections, Recent Patents on Drug Delivery & Formulation 2008; 2 (2) . https://dx.doi.org/10.2174/187221108784534090
DOI https://dx.doi.org/10.2174/187221108784534090 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
12
Related Articles
-
Infections and Atheromatous Plaque: Current Therapeutic Implications
Current Pharmaceutical Design Activation and Activators of TRPV1 and Their Pharmaceutical Implication
Current Pharmaceutical Design Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Current Cancer Drug Targets Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
Current Pharmaceutical Design Role of Osmolytes in Regulating Immune System
Current Pharmaceutical Design Characterization of Plant-Bacterial Interactions Using Proteomic Approaches
Current Proteomics Phosphotyrosine Phosphatases in Cancer Diagnostic and Treatment
Recent Patents on DNA & Gene Sequences ADAM Proteases: Protective Role in Alzheimers and Prion Diseases ?
Current Alzheimer Research The HIV Life Cycle: Multiple Targets for Antiretroviral Agents
Drug Design Reviews - Online (Discontinued) Endothelin-1 Signaling in Vascular Physiology and Pathophysiology
Current Vascular Pharmacology Heart Transplantation in Biventricular Congenital Heart Disease: Indications, Techniques, and Outcomes
Current Cardiology Reviews Fungal Gene-Encoded Peptidase Inhibitors
Current Medicinal Chemistry Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice
CNS & Neurological Disorders - Drug Targets STAT3: A Molecular Target for Cancer Whose Time Has Come
Current Signal Transduction Therapy Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands
Current Medicinal Chemistry Differentiation of iNKT Cells from Embryonic Stem Cells
Current Immunology Reviews (Discontinued) Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Target Therapies in Pancreatic Carcinoma
Current Medicinal Chemistry Patent Selections
Recent Patents on DNA & Gene Sequences Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism